Identification of presynaptic neurotoxin complexes in the venoms of three Australian copperheads (Austrelaps spp.) and the efficacy of tiger snake antivenom to prevent or reverse neurotoxicity

Toxicon

Volumn 58, Issue 5, 2011, Pages 439-452

  Marcon, Francesca ^a   Nicholson, Graham M ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Australian copperhead; Austrelaps; Neurotoxicity; Neurotransmitter release; Snake antivenom; Snake presynaptic phospholipase A2 neurotoxin

Indexed keywords

NEUROTOXIN; PHOSPHOLIPASE A2; SNAKE VENOM; SNAKE VENOM ANTISERUM;

ANIMAL TISSUE; ARTICLE; AUSTRELAP LABIALIS; AUSTRELAP RAMSAYI; COMPLEX FORMATION; CONTROLLED STUDY; DRUG EFFICACY; ENVENOMATION; ENZYME ACTIVITY; GEL PERMEATION CHROMATOGRAPHY; IN VITRO STUDY; MALE; MOLECULAR WEIGHT; MUSCLE TWITCH; NERVE POTENTIAL; NEUROTOXICITY; NONHUMAN; POISONOUS SNAKE; POSTSYNAPTIC INHIBITION; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; TOXIN ANALYSIS;

AGKISTRODON; ANIMALS; ANTIVENINS; CHICKENS; CHROMATOGRAPHY, GEL; CROTALID VENOMS; LETHAL DOSE 50; MALE; MOLECULAR WEIGHT; PHOSPHOLIPASES A2; PRESYNAPTIC TERMINALS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

AGKISTRODON; AUSTRELAPS; AUSTRELAPS SUPERBUS; SPILOTES PULLATUS PULLATUS;

EID: 80052649063     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2011.08.003     Document Type: Article

References (42)

1. Aquilina J.A. The major toxin from the Australian Common Brown Snake is a hexamer with unusual gas-phase dissociation properties. Proteins 2009, 75:478-485.
2. Birrell G.W., Earl S.T., Wallis T.P., Masci P.P., de Jersey J., Gorman J.J., Lavin M.F. The diversity of bioactive proteins in Australian snake venoms. Mol Cell Proteomics 2007, 6:973-986.
3. Blacklow B., Escoubas P., Nicholson G.M. Characterisation of the heterotrimeric presynaptic phospholipase A2 neurotoxin complex from the venom of the common death adder (Acanthophis antarcticus). Biochem Pharmacol. 2010, 80:277-287.
4. Blacklow B., Konstantakopoulos N., Hodgson W.C., Nicholson G.M. Presence of presynaptic neurotoxin complexes in the venoms of Australo-Papuan death adders (Acanthophis spp.). Toxicon 2010, 55:1171-1180.
5. Broad A.J., Sutherland S.K., Coulter A.R. The lethality in mice of dangerous Australian and other snake venom. Toxicon 1979, 17:661-664.
6. Chaisakul J., Konstantakopoulos N., Smith A.I., Hodgson W.C. Isolation and characterisation of P-EPTX-Ap1a and P-EPTX-Ar1a: pre-synaptic neurotoxins from the venom of the northern (Acanthophis praelongus) and Irian Jayan (Acanthophis rugosus) death adders. Biochem Pharmacol. 2010, 80:895-902.
7. Chetty N., Du A., Hodgson W.C., Winkel K.D., Fry B.G. The in vitro neuromuscular activity of Indo-Pacific sea-snake venoms: efficacy of two commercially available antivenoms. Toxicon 2004, 44:193-200.
8. Chippaux J.P., Williams V., White J. Snake venom variability: methods of study, results and interpretation. Toxicon 1991, 29:1279-1303.
9. Chu C.C., Li S.H., Chen Y.H. Resolution of isotoxins in the β-bungarotoxin family. J Chromatogr A 1995, 694:492-497.
10. Currie B.J. Treatment of snakebite in Australia: the current evidence base and questions requiring collaborative multicentre prospective studies. Toxicon 2006, 48:941-956.
11. Doley R., Tram N.N., Reza M.A., Kini R.M. Unusual accelerated rate of deletions and insertions in toxin genes in the venom glands of the pygmy copperhead (Austrelaps labialis) from Kangaroo island. BMC Evol Biol 2008, 8:70.
12. Fohlman J., Eaker D., Karlsson E., Thesleff S. Taipoxin, an extremely potent presynaptic neurotoxin from the venom of the Australian snake taipan (Oxyuranus s. scutellatus). Isolation, characterization, quaternary structure and pharmacological properties. Eur J Biochem 1976, 68:457-469.
13. Frobert Y., Creminon C., Cousin X., Remy M.H., Chatel J.M., Bon S., Bon C., Grassi J. Acetylcholinesterases from Elapidae snake venoms: biochemical, immunological and enzymatic characterization. Biochim Biophys Acta 1997, 1339:253-267.
14. Ginsborg B.L., Warriner J. The isolated chick biventer cervicis nerve-muscle preparation. Brit J Pharmacol Chemother 1960, 15:410-411.
15. Harris J.B., Karlsson E., Thesleff S. Effects of an isolated toxin from Australian Tiger snake (Notechis scutatus scutatus) venom at the mammalian neuromuscular junction. Brit J Pharmacol. 1973, 47:141-146.
16. Harris J.B., Grubb B.D., Maltin C.A., Dixon R. The neurotoxicity of the venom phospholipases A2, notexin and taipoxin. Exp Neurol. 2000, 161:517-526.
17. Harvey A.L., Barfaraz A., Thomson E., Faiz A., Preston S., Harris J.B. Screening of snake venoms for neurotoxic and myotoxic effects using simple in vitro preparations from rodents and chicks. Toxicon 1994, 32:257-265.
18. Hodgson W.C., Eriksson C.O., Alewood P., Fry B.G. Comparison of the in vitro neuromuscular activity of venom from three Australian snakes (Hoplocephalus stephensi, Austrelaps superbus and Notechis scutatus): efficacy of tiger snake antivenom. Clin Exp Pharmacol Physiol. 2003, 30:127-132.
19. Hodgson W.C., Dal Belo C.A., Rowan E.G. The neuromuscular activity of paradoxin: a presynaptic neurotoxin from the venom of the inland taipan (Oxyuranusmicrolepidotus). Neuropharmacology 2007, 52:1229-1236.
20. Jin Y., Lee W.H., Zeng L., Zhang Y. Molecular characterization of L-amino acid oxidase from king cobra venom. Toxicon 2007, 50:479-489.
21. Kini R.M. Phospholipase A2-a complex multifunctional protein puzzle. Venom Phospholipase A2 Enzymes: Structure, Function and Mechanism 1997, 1-28. John Wiley & Sons Ltd., Chichester. R.M. Kini (Ed.).
22. Kuruppu S., Reeve S., Banerjee Y., Kini R.M., Smith A.I., Hodgson W.C. Isolation and pharmacological characterization of cannitoxin, a presynaptic neurotoxin from the venom of the Papuan Taipan (Oxyuranus scutellatus canni). J Pharmacol Exp Ther 2005, 315:1196-1202.
23. Kuruppu S., Reeve S., Smith A.I., Hodgson W.C. Isolation and pharmacological characterisation of papuantoxin-1, a postsynaptic neurotoxin from the venom of the Papuan black snake (Pseudechis papuanus). Biochem Pharmacol 2005, 70:794-800.
24. Kuruppu S., Smith A.I., Isbister G.K., Hodgson W.C. Neurotoxins from Australo-Papuan elapids: a biochemical and pharmacological perspective. Crit Rev Toxicol. 2008, 38:73-86.
25. Lin L.P., Lin Q., Wang Y.Q. Cloning, expression and characterization of two C-type lectins from the venom gland of Bungarus multicinctus. Toxicon 2007, 50:411-419.
26. Lumsden N.G., Fry B.G., Ventura S., Kini R.M., Hodgson W.C. Pharmacological characterisation of a neurotoxin from the venom of Boiga dendrophila (mangrove catsnake). Toxicon 2005, 45:329-334.
27. Mebs D., Samejima Y. Purification, from Australian elapid venoms, and properties of phospholipases A which cause myoglobinuria in mice. Toxicon 1980, 18:443-454.
28. O'Leary M.A., Isbister G.K. Commercial monovalent antivenoms in Australia are polyvalent. Toxicon 2009, 54:192-195.
29. Ramasamy S., Isbister G.K., Hodgson W.C. The efficacy of two antivenoms against the in vitro myotoxic effects of black snake (Pseudechis) venoms in the chick biventer cervicis nerve-muscle preparation. Toxicon 2004, 44:837-845.
30. Rawlinson P.A. Taxonomy and distribution of the australian tiger snakes (Notechis) and copperheads (Austrelaps) (Serpentes, Elapidae). Proc Royal Soc Victoria 1991, 103:125-135.
31. Rigoni M., Paoli M., Milanesi E., Caccin P., Rasola A., Bernardi P., Montecucco C. Snake phospholipase A2 neurotoxins enter neurons, bind specifically to mitochondria, and open their transition pores. J Biological Chemistry 2008, 283:34013-34020.
32. Rosenberg P. Lethal potency of snake venom phospholipase A2 enzymes. Venom Phospholipase A2 Enzymes: Structure, Function and Mechanism 1997, 129-154. John Wiley & Sons Ltd., Chichester. R.M. Kini (Ed.).
33. Rossetto O., Rigoni M., Montecucco C. Different mechanism of blockade of neuroexocytosis by presynaptic neurotoxins. Toxicol Lett 2004, 149:91-101.
34. Singh S., Armugam A., Kini R.M., Jeyaseelan K. Phospholipase A2 with platelet aggregation inhibitor activity from Austrelaps superbus venom: protein purification and cDNA cloning. Arch Biochem Biophys 2000, 375:289-303.
35. Su M.J., Coulter A.R., Sutherland S.K., Chang C.C. The presynaptic neuromuscular blocking effect and phospholipase A2 activity of textilotoxin, a potent toxin isolated from the venom of the Australian brown snake, Pseudonaja textilis. Toxicon 1983, 21:143-151.
36. Subburaju S., Kini R.M. Isolation and purification of superbins I and II from Austrelaps superbus (copperhead) snake venom and their anticoagulant and antiplatelet effects. Toxicon 1997, 35:1239-1250.
37. Sutherland S.K., Tibballs J. Genus Austrelaps, death adders. Australian Animal Toxins: The Creatures, Their Toxins and Care of the Poisoned Patient 2001, Oxford University Press, Melbourne, 130-138.
38. Tan N., Ponnudurai G. A comparative study of the biological properties of Australian elapid venoms. Comp Biochem Physiol. 1990, 97C:99-106.
39. White J. Envenoming and antivenom use in Australia. Toxicon 1998, 36:1483-1492.
40. White J. CSL Antivenom Handbook 2001, CSL Ltd., Melbourne.
41. Wickramaratna J.C., Fry B.G., Aguilar M.I., Kini R.M., Hodgson W.C. Isolation and pharmacological characterization of a phospholipase A2 myotoxin from the venom of the Irian Jayan death adder (Acanthophis rugosus). Brit J Pharmacol 2003, 138:333-342.
42. Yuan Y., Jackson S.P., Mitchell C.A., Salem H.H. Purification and characterisation of a snake venom phospholipase A2: a potent inhibitor of platelet aggregation. Thromb Res 1993, 70:471-481.